Followers | 191 |
Posts | 6887 |
Boards Moderated | 1 |
Alias Born | 10/05/2010 |
Thursday, April 24, 2014 3:07:39 PM
1. Product market expansion and revenue growth (300% range)
2. Margin improvement (Q3 .5% - Q4 13.1%)
3. Moving into CBD market (purchased supercritical CO2 extractor)
4. Submitted application in NV for MJ growing permit(s)
5. Cancelled 12.4M shares from financing deal (Hanover), New S-3 will provide much better financing deal for CO and shareholders
Going to be a great year for TRTC shareholders.
Knife
TRTC
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM